openPR Logo
Press release

The Basic Information About Orlistat

According to statistics from the World Health Organization (WHO), nearly 2 billion people are overweight or obese worldwide. Every year, overweight or obesity causes 2.8 million deaths.

What 's Orlistat ?

Orlistat is a lipase inhibitor used in the treatment of obesity that works by inhibiting fat-metabolizing enzymes. It was originally approved by the FDA in 1999 as the prescription drug Exenical, was approved in 2007 as the over-the-counter medication Alli. This drug is a generally well-tolerated and effective weight-loss aid.

What 's the mechanism of action?

Orlistat is a drug designed to treat obesity. It'sa potent and selective inhibitor of various lipase enzymes responsible for the metabolism of fat. It acts in the gastrointestinal (GI) tract via covalent binding to the serine residues located on the active site of both When orlistat is taken with food containing fat, it partially inhibits the enzymes of triglycerides. This decreases absorption of monoaclglycerides and free fatty acids, contributing to weight maintenance and weight loss.

What 's the side effects of the Orlistat ?

The main side effects of this drug are related to the gastrointestinal tract.

Abdominal pain or discomfort:
Oily discharge from the anus
Gas with oily anal discharge
Oily stools
More-frequent bowel movements
Urgent or hard-to-control bowel movements

Other possible side effects include:
Headache
Back pain
Upper respiratory infection

Huateng Pharma is a global supplier of pharmaceutical intermediates, PEG derivatives, investigateds, APIs and other chemical products. We are dedicated to supplying a wide range of pharmaceutical intermediates to serve customers in the world, such as anti-cancer series, anti-viral series We supply 3-Hexyltetrahydro-4-hydroxy-6-undecyl-2H-pyran-2-one (CAS NO.104801-96-9) with capacities varying from gram to kilograms, anti-diabetic series, antihypertensieve series and so on. It is used in preparation of Orlistat excipient F for quality control of Orlistat and its active pharmaceutical ingredient. This product is an intermediate of Orlistat and ready for mass production.

Hunan Huateng Pharmaceutical Co. Ltd.
Address: Lugu Business Plaza E1, Yuelu District, Changsha City, Hunan Province, China
Manufacturing Base: Tongguan Kiln, Wangcheng district, Changsha, Hunan, China
Email: sales@huatengusa.com
Website: https://us.huatengsci.com
Zip code: 410205
Telephone: +86 731 89916275
Fax: +86 0731-82251112-818

Huateng Pharma is a leading and professional manufacturer which can provide pharmaceutical intermediates, PEG derivatives, biochemical reagents, APIs, Vitamin D Derivatives and so on. We are committed to providing cost-effective pharmaceutical products and services to customers around the world with the belief of "Strive for the Human Health".

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Basic Information About Orlistat here

News-ID: 2562262 • Views:

More Releases from Hunan Huateng Pharmaceutical Co. Ltd.

Huateng Pharma Supplies Minoxidil Intermediate 2,4-Diamino-6-chloropyrimidine (CAS NO.156-83-2)
Huateng Pharma Supplies Minoxidil Intermediate 2,4-Diamino-6-chloropyrimidine (C …
Minoxidil was first introduced by Upjohn Company of the United States, and was first used as an oral drug for the treatment of refractory hypertension in the 1970s. In later clinical applications, doctors observed hair regrowth and generalized excessive hair in balding patients, which led to the development of minoxidil preparations. Minoxidil can increase local blood supply, stimulate the proliferation and differentiation of hair follicle epithelial cells, so as to promote
Huateng Pharma Supplies Anti-diabetic API Intermediates With Huge Stock
Huateng Pharma Supplies Anti-diabetic API Intermediates With Huge Stock
Diabetes is a serious chronic disease characterized by elevated blood sugar concentrations associated with the effects of abnormal beta cell biology on insulin action. Diabetes occurs when the pancreas does not produce enough insulin or the body does not use the insulin it does produce efficiently. The most common forms of diabetes are type 1 diabetes and type 2 diabetes. Type 1 diabetes is characterized by insufficient insulin production and
Huateng Pharma Supplies Some Intermediates of CDK4/6 Inhibitors for Treatment of Advanced Breast Cancer
Huateng Pharma Supplies Some Intermediates of CDK4/6 Inhibitors for Treatment of …
Breast cancer is the most frequent cancer among women, impacting 2.1 million women each year, and also causes the greatest number of cancer-related deaths among women. In 2018, it is estimated that 627,000 women died from breast cancer - that is approximately 15% of all cancer deaths among women. While breast cancer rates are higher among women in more developed regions, rates are increasing in nearly every region globally. The majority
ADC Drugs For HER2 Positive Breast Cancer
ADC Drugs For HER2 Positive Breast Cancer
According to the latest data, breast cancer has overtaken lung cancer to become the most common cancer among women, and the death rate is the second highest among female tumors, seriously affecting the physical and mental health of women around the world. Patients with abnormal expression of human epidermal growth factor receptor (HER2) account for 15%-20% of all breast cancers, which is highly invasive and has poor prognosis. Although more drug

All 5 Releases


More Releases for Orlistat

Global Orlistat Market 2021 Industry Dynamics, Segmentation and Competition Anal …
MarketsandResearch.biz has introduced a new report titled Global Orlistat Market Growth 2021-2026 into its database that’s shaped by the means of primary and secondary research processes. The report comprises a detailed study of the along with the industry trends, size, share, growth drivers, challenges, competitive analysis, and revenue. The report includes an analysis of the overall global Orlistat market competition as well as the product portfolio of major players functioning in the market.
Orlistat Market Market - Size, Share, Outlook, and Forecast till 2026
Orlistat is a drug that is used to treat obesity by preventing the absorption of fats from human diet. It acts as a lipase inhibitor to carry out this process and therefore, the caloric intake is reduced. This drug is usually used along with a healthcare provider-supervised reduced-calorie diet. Orlistat, a saturated derivative of lipstatin, was chosen for the development of an anti-obesity drug due to its simplicity and stability.
Orlistat Market: Overview with Detailed Analysis, Competitive landscape Forecast …
Orlistat Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Orlistat market research report is a professional and in-depth study on the current state of Orlistat Industry. The Orlistat Market research report covers the present scenario and the growth prospects of the global Orlistat industry
Orlistat Market 2017: Keyplayers Roche, GSK group, Teva, Sandoz(Novartis)
QY Research Groups has published its new and latest market report based on thorough research on the Orlistat Market . This detailed, all-inclusive report renders an integrated approach to growth of the market along with an elaborate and accurate analysis of the complete competitive situation of this market on a global level with the key market trends and newest technologies, being a major part in the market’s growth during the
Orlistat Market to Witness A Pronounce Growth during 2022 Forecast in Top Countr …
The “Global Orlistat Market Research Report” is a professional and in-depth study on the current state of the Orlistat Market. The study offers an insight into current and future market trends, key drivers and restraints, market strategies of key market players along with detailed segmentation and forecast. The study offers industry overview by covering basic aspects such as product definition and classification, market size and share of segments and sub-segments.
Orlistat Pellets Market Analysis - Size, Share, Growth, Forecast, Segment, Appli …
Market Research Globe has published its new and latest market report based on thorough research on the Orlistat Pellets Market. This detailed, all-inclusive report renders an integrated approach to growth of the market along with an elaborate and accurate analysis of the complete competitive situation of this market on a global level with the key market trends and newest technologies, being a major part in the market’s growth during the